Fact CheckerSign in

NCT07049692Recruiting

Hyperbaric Oxygen After Stroke Thrombectomy: A Multicenter Randomized Trial on Safety and Efficacy

Evaluation of the Efficacy and Safety of Hyperbaric Oxygen in Patients After Endovascular Treatment for Acute Ischemic Stroke: A Multicenter, Open-label, Randomized Controlled Clinical Trial

Source: ClinicalTrials.gov · Last updated 24 Jul 2026

Brief summary (registry, in English)

1. The goal of this clinical trial is to evaluate the efficacy and safety of hyperbaric oxygen (HBO)in stroke patients after endovascular treatment 2. The main questions it aims to answer is: Whether HBO can improve the prognosis of ischemic stroke patients after endovascular treatment? 3. Participants will: receive HBO (1.6 Atmosphere Absolute,1.6ATA),Once a day, for 1 hour each time, for 5 days a week (it can be non-consecutive days), the total course of treatment is 10 times. undergo three scheduled face to face or telephone follow-up assessments during the 12-month period following HBO.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
424 (estimated)
First submitted
13 Jun 2025
Start date
22 Jul 2026
Primary completion date
30 Mar 2028
Lead sponsor
Beijing Chao Yang Hospital
Diseases
Stroke
NCT number
NCT07049692

What you commit to

  • Study type: Interventional
  • Planned participants: 424
  • From 22 Jul 2026 to the primary completion date, 30 Mar 2028
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Currently involving in the research of other projects related to drugs or medical devices.

Other illness

  • Postprocedural imaging identified either procedure-related subarachnoid hemorrhage or hemorrhagic transformation
  • Severe heart, liver and kidneys failure
  • Unstable vital signs (heart rate ≤ 50 beats/min or ≥ 120 beats/min, oxygen saturation ≤ 90%, respiration ≥ 30 breaths/min or ≤ 10 breaths/min);
  • Hypertension that cannot be controlled by medication: Systolic blood pressure ≥ 160 mmHg, or diastolic blood pressure ≥ 100 mmHg;
  • Suspected of having acute myocardial infarction;
  • CT angiography or magnetic resonance angiography confirmed the presence of cerebral vasculitis or cerebral vasculitis syndrome;

Lab values

  • Hereditary or acquired bleeding tendency, deficiency of coagulation factors, recent use of oral anticoagulants with an international normalized ratio (INR) \> 3 or activated partial thromboplastin time (APTT) exceeding the normal value by more than 3 times
  • Baseline platelet count \< 50×10 9/L
  • Baseline blood glucose is less than 2.78 mmol/L or greater than 22.2 mmol/L.

Other

  • Subjects with HBO contraindications or intolerance
  • Based on the medical history, it is suspected that the cerebral embolism is caused by sepsis or infective endocarditis
  • Expected lifespan \< 90 days
  • Pregnancy
  • CT or MRI scans revealed intracranial tumors (except for cerebellar meningiomas) and intracranial arteriovenous malformations.
  • Based on the medical history and CT or MRI findings, a diagnosis of internal carotid artery dissection or aortic dissection is suspected;
  • Based on the medical history and CT or MRI findings, cerebral vasculitis is suspected.
  • Based on the clinical evidence of multiple vascular regions being occluded (either in the bilateral anterior circulation or anterior/posterior circulation) or bilateral infarction or multi-region infarction as detected by CT angiography or magnetic resonance angiography;
  • CT or magnetic resonance imaging shows a significant midline shift effect (\> 0.5 cm);

Who the study is looking for

  • 35-75 years
  • The symptoms and signs are consistent with acute anterior circulation ischemic stroke. The immediate postoperative angiographic recanalization grade was ≥ 2b.
  • Neurological deficit score at the time of enrollment: 5 ≤ NIHSS ≤ 15 points
  • Consciousness status (NIHSS 1a-1b items): 0-1 point
  • Pre-stroke functional status (mRS score): 0-1
  • Time from surgery to randomization grouping: ≤ 72 hours
  • Patient or legal representative who signed the informed consent form
  • Preoperative CT angiography or magnetic resonance angiography confirmed large vessel occlusion (internal carotid artery or middle cerebral artery M1 segment) that was consistent with the symptoms and signs; And the area supplied by the middle cerebral artery in the brain is less than 1/3.
  • A lberta S troke P rogram E arly C T S core ≥ 6

Age in the registry: 35 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Emergency Intensive Care Unit
Coordinator of this site? Confirm its status
BeijingChinaRecruiting
Beijing Chaoyang Hospital, Capital Medical University
Coordinator of this site? Confirm its status
BeijingChinaNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.